PRIMARY OBJECTIVE:~I. To evaluate the change in pain score using the Numerical Rating Scale for pain on an 11-point scale (0-none to 10-worst) from implementation of myofascial release (MFR) versus trigger point injections (TPI) in the treatment of myofascial trigger points (MTP) as noninvasive therapies for post mastectomy pain syndrome (PMPS).~SECONDARY OBJECTIVES:~I. To evaluate the change in medications, particularly opiate medications in the treatment of post mastectomy pain.~II. To evaluate a patient's satisfaction with therapy or treatment throughout the course of the study at each consecutive encounter or follow up.~III. To evaluate a patient's range of motion with therapy or treatment beginning at time of screening and until the end of the study.~IV. To evaluate a patient's degree of lymphedema both subjectively and objectively in the affected extremity(ies) unilateral to the site(s) of mastectomy in response to the various forms of treatment throughout the study.~V. To evaluate quality of life measure changes with treatments used throughout the study.~OUTLINE: Patients are randomized to 1 of 2 arms.~ARM I: Patients receive standard of care trigger point injections at baseline.~ARM II: Patients perform myofascial release for 10 minutes each day.
This clinical trial studies the effect of myofascial release in decreasing post-mastectomy pain compared to standard of care trigger point injections in patients with post-mastectomy pain syndrome. Patients who have mastectomies often experience pain that does not go away after time. This is known as post-mastectomy pain syndrome. Myofascial release is a form of physical therapy in which pressure is applied to the affected areas. Myofascial release may be an effective way of decreasing pain in patients with post-mastectomy pain syndrome without the use of medication.